Sign In | Join Free | My sxprice.org.cn
sxprice.org.cn
Products
Search by Category
Home > Incontinence Care >

Oral Toremifene Citrate selective estrogen receptor modulator For breast cancer treatment

Oral Toremifene Citrate selective estrogen receptor modulator For breast cancer treatment

Categories Oral Anabolic Steroids
Brand Name: ChineseHormone
Model Number: CAS 89778-27-8
Certification: ISO9001,SGS,UKAS
Place of Origin: China
MOQ: Free samples Available
Price: Negotiable
Payment Terms: Western Union, MoneyGram, T/T,Bitcoins
Supply Ability: 500 kg / month
Delivery Time: 3-6 working days
Packaging Details: Discreet package or as required
Email: jack25th@yccreate.com
Skype: carrie.xiao96
Whatsapp: 86-18872220686
Packing: Discreet packing for Customs pass guaranteed
Assay: 99%
CAS: 89778-27-8
MF: C26H28ClNO・C6H8O7
MW: 598.09
  • Haven't found right suppliers
  • Our buyer assistants can help you find the most suitable, 100% reliable suppliers from China.
  • And this service is free of charge.
  • we have buyer assistants who speak English, French, Spanish......and we are ready to help you anytime!
  • Submit Buying Request
    • Product Details
    • Company Profile

    Oral Toremifene Citrate selective estrogen receptor modulator For breast cancer treatment


    Oral Toremifene Citrate selective estrogen receptor modulator For breast cancer treatment


    Toremifene Citrate Quick Details:


    Toremifene citrate is an oral selective estrogen receptor modulator (SERM) which helps oppose the actions of estrogen in the body. Licensed in the United States under the brand name Fareston, toremifene citrate is FDA-approved for use in advanced (metastatic) breast cancer. Toremifene citrate is also being evaluated for prevention of prostate cancer under the brand name Acapodene.


    Product NameToremifene citrate
    Molecular FormulaC26H28ClNO・C6H8O7
    Molecular Weight598.09
    CAS89778-27-8
    Molecular Structure
    AppearanceWhite Crystalline Powder

    Toremifene Citrate Descriptions:


    In 2007 the pharmaceutical company GTx, Inc was conducting two different phase 3 clinical trials; First, a pivotal Phase clinical trial for the treatment of serious side effects of androgen deprivation therapy (ADT) (especially vertebral/spine fractures and hot flashes, lipid profile, and gynecomastia) for advanced prostate cancer, and second, a pivotal Phase III clinical trial for the prevention of prostate cancer in high risk men with high grade prostatic intraepithelial neoplasia, or PIN. Results of these trials are expected by first quarter of 2008.


    An NDA for the first application (relief of prostate cancer ADT side effects) was submitted in Feb 2009, and in Oct 2009 the FDA said they would need more clinical data, e.g. another phase III trial.


    Toremifene Citrate COA:


    TEST ITEMSSPECIFICATIONRESULTS
    DescriptionWhite or Almost White Crystalline PowderWhite Powder
    IdentificationPositivePositive
    Assay97.00~103.00%99.38%
    Loss On Drying0.5%max0.25%
    Melting Point95~99¡ãC96.0~98.0¡ãC
    Specific Rotation+48¡ã~+51¡ã+49.0¡ã
    Organic Volatile Impuritiesmeets the requirments.Conforms
    Residual Solventsmeets the requirments.Conforms
    ConclusionThe specification conform with USP32 standard

    Toremifene Citrate Applications:


    It has already been covered that Toremifene is a SERM, and serves to block Estrogen at various receptor sites in certain tissues within the body (breast tissue in particular). As a layman explanation, Toremifene pretends to be a 'fake' Estrogen that occupies Estrogen receptors within breast tissue. With these receptors occupied by Toremifene, real Estrogen cannot perform their jobs there.


    Toremifene does not reduce total blood plasma levels of Estrogen. In addition to being antagonistic to Estrogen receptors in breast tissue, it is also antagonistic to Estrogen at the hypothalamus gland (this essentially 'tricks' the hypothalamus into thinking there is little or no circulating Estrogen levels in the body, causing it to increase its manufacture of Testosterone so that it can utilize aromatization to restore these levels.



    Related Products:


    Gamma-Butyrolactone(GBL)CAS 96-48-0the intermediate of plant growth stimulator
    and insecticide
    CabergolineCAS 81409-90-7treat different types of medical problems
    IsotretinoinCAS 4759-48-2treat severe cystic acne
    SpironolactoneCAS 52-01-7Used as a diuretic
    MinoxidilCAS 38304-91-5an antihypertensive vasodilator medication
    PhenacetinCAS 62-44-2a cutting agent to adulterate cocaine
    Pramipexole HydrochlorideCAS 191217-81-9Parkinson's disease drug
    Ropinirole HydrochlorideCAS 91374-20-8Used in the treatment of Parkinson's disease
    PramiracetamCAS 68497-62-1nootropic drug derived from piracetam
    Zanamivir HydrateCAS 139110-80-8Influenza viral neuraminidase inhibitor
    MelatoninCAS 73-31-4theentrainment of the circadian rhythms
    Methyl Synephrine HydrochlorideCAS 365-26-4can promote thermogenesis
    Benzyl AlcoholCAS 100-51-6a good middle boiling point solvent
    Benzyl BenzoateCAS 120-51-4used as an acaricide, scabicide, and
    pediculicide
    Ethyl OleateCAS 111-62-6

    Can be used as pharmaceutical material

    Quality Oral Toremifene Citrate selective estrogen receptor modulator For breast cancer treatment for sale
    Send your message to this supplier
     
    From:
    Enter your email please.
    To: HONGKONG YUANCHENG GONGCHUANG TECHNOLOGY Co., LIMITED
    Subject:
    Message:
    Characters Remaining: (0/3000)
     
    Inquiry Cart 0